JPI InvestFranΓ§ais
JPI AI Analyst AI assistant Β· JPI Invest
Answers based on the tool's data Β· not financial advice Β· full analysis (free)
All stocks β€Ί Health Care β€Ί HALO β€Ί Financials

Halozyme (HALO): financial analysis & fundamentals

Health Care Β· price $107 Β· market cap $12.1 B
In short β€” Halozyme trades at 31.4Γ— earnings (P/E), 10.3Γ— expected earnings, for a PEG of 0.73 and a net margin of 25%. Revenue growth 48%. Quick verdict: rather cheap given growth.

πŸ“ˆ See the interactive version (live chart) β†’

πŸ”— Related pages on Halozyme β€” Are analysts right?  Β·  If I had invested

Valuation & profitability

MetricValueWhat it means
P/E (price / earnings)31.4The higher, the more growth the market expects.
Forward P/E10.3On next year's expected earnings. Lower than current P/E = rising earnings.
PEG (P/E Γ· growth)0.73Below 1 = cheap given growth; above 2 = expensive.
Net margin25%Share of revenue that ends up as profit.
Revenue growth48%Pace of revenue growth.
Price-to-book84.9Price relative to book value.
Market cap$12.1 BTotal market value of the company.
Dividend yieldβ€”No dividend currently.

Income statement (by year)

YearRevenueNet incomeNet margin
2022$660 M$202 M31%
2023$829 M$282 M34%
2024$1.0 B$444 M44%
2025$1.4 B$317 M23%

πŸ“Š Open the interactive Halozyme page (charts, live news) β†’

Frequently asked questions

Is Halozyme stock expensive?

Halozyme has a P/E of 31.4 (forward P/E 10.3) and a PEG of 0.73. A PEG below 1 is rather cheap given growth, above 2 is expensive. Verdict: rather cheap given growth.

What is Halozyme's net margin?

Halozyme's net margin is about 25% β€” the share of revenue that ends up as net profit.

What is Halozyme's revenue?

Latest known revenue: $1.4 B for net income of $317 M. The year-by-year breakdown is in the income statement above.

What is Halozyme's market cap?

Halozyme (HALO) has a market cap of about $12.1 B.

Does Halozyme pay a dividend?

No, Halozyme does not currently pay a dividend (it reinvests earnings).

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β€” on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

Explore JPI Invest for free β†’ How it works: the method β†’

⚠️ Educational information, not investment advice. Data: Yahoo Finance, recomputed by JPI Invest. A stock can be « cheap » for a bad reason.